Skip to main content
Signal8
Launch Terminal
Holtzman Steven H profile photo

Steven H. Holtzman

CIK: 0001300247

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Camp4 Therapeutics Corp logo
CAMP

Camp4 Therapeutics Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Jun 10, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    28K shares-
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Jun 25, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    9K shares-
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Oct 15, 2024
    Conversion(C)
    Direct
    8.9K shares-

1-3 of 3

About Holtzman Steven H

Holtzman Steven H (SEC CIK 0001300247) files insider reports with the SEC as Director of Camp4 Therapeutics Corp (CAMP).

Signal8 holds 4 ownership filings by Holtzman Steven H (1 Form 3, 3 Form 4), filed between Oct 10, 2024 and Jun 12, 2026. Those filings report 3 transactions, from Oct 15, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Holtzman Steven H's filings is in CAMBRIDGE, MA.

Recent filings by Holtzman Steven H

  • Jun 10, 2026: Grant or award of CAMP derivative securities (Form 4, code A).
  • Jun 25, 2025: Grant or award of CAMP derivative securities (Form 4, code A).
  • Oct 15, 2024: Conversion of CAMP shares (Form 4, code C).

Other insiders filing for Camp4 Therapeutics Corp (CAMP)

How to read Form 4 transaction codes